Rozenbaum et al found that the CAR transduction efficiency of γδ T-cells was as high as that of standard CAR-T cells during production; in terms of anti-tumor effects, CD19-directed γδ T-cells were effective against both CD19-positive and negative leukemic cells.141. This evidence concerns the gene CD19 and neoplasm.